Bilgin, SatılmışAktaş, GülaliKurtkulağı, ÖzgeAtak, Burçin MeryemDuman, Tuba Taslamacıoğlu2021-06-232021-06-2320202251-6581https://doi.org/10.1007/s40200-020-00542-zhttps://hdl.handle.net/20.500.12491/10469Purpose We aimed to observe clinical and laboratory indices of the diabetic subjects who were either frail or not according to Edmonton frail score. We also aimed to study whether Edmonton frail score was correlated with metabolic and other parameters of the diabetic subjects. Methods Patients with T2DM visited our clinic were enrolled to the study and grouped as either frail or not frail according to the Edmonton score. Clinical and laboratory parameters of the groups were compared. Results Serum triglyceride (p = 0.04), serum albumin (p = 0.006) and Glomerular Filtration Rate (GFR) (p = 0.01) were significantly lower, while fasting blood glucose (FBG) (p = 0.02), HDL cholesterol (p = 0.005) and glycated hemoglobin (HbA1c) (p = 0.04) were significantly higher in frail group compared to the not frail patients. Edmonton frail score was positively correlated with HbA1c, age, duration of T2DM, FBG, and negatively correlated with serum albumin and GFR levels. Conclusions We think that frailty is associated with poor glucose control in subjects with T2DM and better control of the disease may prevent or slow down the development of frailty, as well as microvascular complications in subjects with type 2 diabetes mellitus.eninfo:eu-repo/semantics/closedAccessType 2 Diabetes MellitusFrailtyHbA1cEdmonton Frail ScoreArticle10.1007/s40200-020-00542-z191511514325502032-s2.0-85084589509Q2WOS:000533250000001N/A